Evidence map›Paper›PMID 39940788›Full record

ReviewInternational journal of molecular sciences2025

The Role of mtDNA Mutations in Atherosclerosis: The Influence of Mitochondrial Dysfunction on Macrophage Polarization.

Evgeniya I Fedotova, Alexey V Berezhnov, Daniil Y Popov, Elena Y Shitikova, Andrey Y Vinokurov

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Targeted drug delivery systems for atherosclerosis.Journal of nanobiotechnology · 2025
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Evgeniya I FedotovaInstitute of Cell Biophysics of the Russian Academy of Sciences, Pushchino 142290, Russia.ORCID 0000-0001-6619-4563
Alexey V BerezhnovInstitute of Cell Biophysics of the Russian Academy of Sciences, Pushchino 142290, Russia.ORCID 0000-0003-0271-6179
Daniil Y PopovCell Physiology and Pathology Laboratory, Orel State University, Orel 302026, Russia.ORCID 0000-0002-9436-1346
Elena Y ShitikovaCell Physiology and Pathology Laboratory, Orel State University, Orel 302026, Russia.
Andrey Y VinokurovCell Physiology and Pathology Laboratory, Orel State University, Orel 302026, Russia.ORCID 0000-0001-8436-1353

Funding

Russian Science Foundation 22-15-00317
6 · The paper itself

Abstract

Atherosclerosis is a complex inflammatory process associated with high-mortality cardiovascular diseases. Today, there is a growing body of evidence linking atherosclerosis to mutations of mitochondrial DNA (mtDNA). But the mechanism of this link is insufficiently studied. Atherosclerosis progression involves different cell types and macrophages are one of the most important. Due to their high plasticity, macrophages can demonstrate pro-inflammatory and pro-atherogenic (macrophage type M1) or anti-inflammatory and anti-atherogenic (macrophage type M2) effects. These two cell types, formed as a result of external stimuli, differ significantly in their metabolic profile, which suggests the central role of mitochondria in the implementation of the macrophage polarization route. According to this, we assume that mtDNA mutations causing mitochondrial disturbances can play the role of an internal trigger, leading to the formation of macrophage M1 or M2. This review provides a comparative analysis of the characteristics of mitochondrial function in different types of macrophages and their possible associations with mtDNA mutations linked with inflammation-based pathologies including atherosclerosis.

Indexed as

AtherosclerosisDNA, MitochondrialMacrophagesMitochondriaMutationAnimalsHumansInflammationMacrophage ActivationDNA, MitochondrialatherosclerosisinflammationmacrophagesmtDNAmutationspolarization

Identifiers

PMID39940788
PMCPMC11817597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.